Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Ann Surg Oncol] 2020 Jun; Vol. 27 (6), pp. 2061-2070. <i>Date of Electronic Publication: </i>2019 Dec 20.
- MeSH Terms: Adenocarcinoma of Lung / *diagnostic imaging ; Adenocarcinoma of Lung / *pathology ; Neoplasms, Multiple Primary / *diagnostic imaging ; Adenocarcinoma / pathology ; Adenocarcinoma of Lung / mortality ; Aged ; China ; Disease-Free Survival ; Female ; Humans ; Lung Neoplasms / pathology ; Male ; Middle Aged ; Neoplasm Staging ; Neoplasms, Multiple Primary / mortality ; Neoplasms, Multiple Primary / pathology ; Proportional Hazards Models ; Retrospective Studies ; Tomography, X-Ray Computed
- References: Ishikawa Y, Nakayama H, Ito H, et al. Surgical treatment for synchronous primary lung adenocarcinomas. Ann Thorac Surg. 2014;98:1983–8. (PMID: 10.1016/j.athoracsur.2014.07.006) ; Zhang Y, Hu H, Wang R, et al. Synchronous non-small cell lung cancers: diagnostic yield can be improved by histologic and genetic methods. Ann Surg Oncol. 2014;21:4369–74. (PMID: 10.1245/s10434-014-3840-1) ; Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606–12. (PMID: 10.1016/S0022-5223(19)40289-4) ; Chung JH, Choe G, Jheon S, et al. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread. J Thorac Oncol. 2009;4:1490–5. (PMID: 10.1097/JTO.0b013e3181bc9731) ; Girard N, Deshpande C, Lau C, et al. Comprehensive histologic assessment helps to differentiate multiple lung primary non-small cell carcinomas from metastases. Am J Surg Pathol. 2009;33:1752–64. (PMID: 10.1097/PAS.0b013e3181b8cf03) ; Girard N, Deshpande C, Azzoli CG, et al. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines. Chest. 2010;137:46–52. (PMID: 10.1378/chest.09-0325) ; Warth A, Macher-Goeppinger S, Muley T, et al. Clonality of multifocal non-small cell lung cancer: implications for staging and therapy. Eur Respir J. 2012;39:1437–42. (PMID: 10.1183/09031936.00105911) ; Murphy SJ, Aubry MC, Harris FR, et al. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small cell lung cancer. J Clin Oncol. 2014;32(36):4050–8. (PMID: 10.1200/JCO.2014.56.7644) ; Sun W, Liu Y, Liu XY, Lin DM, Lv N. Significance of nonmucinous lepidic component with mild nuclear atypia in the discrimination of multiple primary lung cancers from intrapulmonary metastases. Int J Clin Exper Pathol. 2014;7:7583–96. ; Detterbeck FC, Nicholson AG, Franklin WA, et al. The IASLC Lung Cancer Staging Project: summary of proposals for revisions of the classification of lung cancers with multiple pulmonary sites of involvement in the forthcoming eighth edition of the TNM classification. J Thorac Oncol. 2016;11:639–50. ; Gu B, Burt BM, Merritt RE, et al. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease. Ann Thorac Surg. 2013;96:411–8. (PMID: 10.1016/j.athoracsur.2013.04.048) ; Ye T, Deng L, Wang S, et al. Lung adenocarcinomas manifesting as radiological part-solid nodules define a special clinical subtype. J Thorac Oncol. 2019;14:617–27. (PMID: 10.1016/j.jtho.2018.12.030) ; Fu F, Zhang Y, Wen Z, et al. Distinct prognostic factors in patients with stage I non-small cell lung cancer with radiologic part solid or solid lesions. J Thorac Oncol. 2019;14(12):2133–42. (PMID: 10.1016/j.jtho.2019.08.002) ; Ye T, Deng L, Xiang J, et al. Predictors of pathologic tumor invasion and prognosis for ground-glass opacity featured lung adenocarcinoma. Ann Thorac Surg. 2018;106:1682–90. (PMID: 10.1016/j.athoracsur.2018.06.058) ; Liu S, Wang R, Zhang Y, et al. Precise diagnosis of intraoperative frozen section is an effective method to guide resection strategy for peripheral small-sized lung adenocarcinoma. J Clin Oncol. 2016;34:307–13. (PMID: 10.1200/JCO.2015.63.4907) ; Ettinger DS, Wood DE, Akerley W, et al. Non-small cell lung cancer, version 1.2015. JNCCN J Natl Comprehensive Cancer Network. 2014;12:1738–61. ; Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011;6:244–85. (PMID: 10.1097/JTO.0b013e318206a221) ; Warth A, Muley T, Meister M, et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol. 2012;30:1438–46. (PMID: 10.1200/JCO.2011.37.2185) ; Hu H, Sun Z, Li Y, et al. The histologic classifications of lung adenocarcinomas are discriminable by unique lineage backgrounds. J Thorac Oncol. 2016;11(12):2161–72. (PMID: 10.1016/j.jtho.2016.07.016) ; Zhang Y, Wang R, Cai D, et al. A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component. J Thorac Oncol. 2014;9:1772–8. (PMID: 10.1097/JTO.0000000000000341) ; Zhang Y, Li J, Wang R, et al. The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma. Sci Rep. 2014;4:7163. (PMID: 10.1038/srep07163) ; Tsao MS, Marguet S, Le Teuff G, et al. Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection. J Clin Oncol. 2015;33:3439–46. (PMID: 10.1200/JCO.2014.58.8335) ; Gazdar AF, Minna JD. Multifocal lung cancers: clonality vs field cancerization and does it matter? J Natl Cancer Institute. 2009;101:541–3. (PMID: 10.1093/jnci/djp059) ; Detterbeck FC, Marom EM, Arenberg DA, et al. The IASLC Lung Cancer Staging Project: background data and proposals for the application of TNM staging rules to lung cancer presenting as multiple nodules with ground-glass or lepidic features or a pneumonic type of involvement in the forthcoming eighth edition of the TNM classification. J Thorac Oncol. 2016;11:666–80. ; Detterbeck FC, Franklin WA, Nicholson AG, et al. The IASLC Lung Cancer Staging Project: background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:651–65. ; Detterbeck FC, Bolejack V, Arenberg DA, et al. The IASLC Lung Cancer Staging Project: background data and proposals for the classification of lung cancer with separate tumor nodules in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:681–92. ; Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The 8th-edition lung cancer stage classification. Chest. 2017;151(1):193–203. (PMID: 10.1016/j.chest.2016.10.010) ; Kadota K, Nitadori J, Sima CS, et al. Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas. J Thorac Oncol. 2015;10:806–14. (PMID: 10.1097/JTO.0000000000000486) ; Kim HK, Choi YS, Kim K, et al. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer. J Thorac Oncol. 2009;4:1242–6. (PMID: 10.1097/JTO.0b013e3181b3fee3) ; Donington JS. An additional step toward personalization of surgical care for early-stage non-small cell lung cancer. J Clin Oncol. 2016;34:295–6. (PMID: 10.1200/JCO.2015.64.7578) ; Baisi A, De Simone M, Raveglia F, Cioffi U. What really affects synchronous pulmonary adenocarcinoma management? Ann Thorac Surg. 2015;100:1506–7. (PMID: 10.1016/j.athoracsur.2015.01.054) ; Zhao Y, Wang R, Shen X, et al. Minor components of micropapillary and solid subtypes in lung adenocarcinoma are predictors of lymph node metastasis and poor prognosis. Ann Surg Oncol. 2016;23:2099–105. (PMID: 10.1245/s10434-015-5043-9)
- Grant Information: 2017ZZ02025 Shanghai Municipal Health Commission Key Discipline Project; 2017ZZ01019 Shanghai Municipal Health Commission Key Discipline Project; 81572253 The National Natural Science Foundation of China; SHDC12017102 Shanghai Shenkang Hospital Development Center City Hospital Emerging Cutting-edge Technology Joint Research Project
- Entry Date(s): Date Created: 20191222 Date Completed: 20210202 Latest Revision: 20210706
- Update Code: 20231215
|